Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.
Mateo
I
I
Infante
J
J
Rodríguez
E
E
Berciano
J
J
Combarros
O
O
Llorca
J
J
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000235:genetics*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D002540:Cerebral Cortex / Q000201:enzymology; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000235:genetics*; D004843:Epistasis, Genetic; D005260:Female; D005838:Genotype; D006801:Humans; D007375:Interleukin-1 / Q000235:genetics*; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D011110:Polymorphism, Genetic / Q000235:genetics; D012306:Risk
D016229:Amyloid beta-Peptides; D007375:Interleukin-1; D015850:Interleukin-6; D004299:Dopamine beta-Hydroxylase; D004298:Dopamine; D009638:Norepinephrine